- Home
- / ISR Immune System Regulation Holding
ISR Immune System Regulation Holding
ISR Immune System Regulation Holding Summary
Company Summary
- Overview
- ISR Immune System Regulation Holding is a research company specializing in immunotherapy. It focuses on preclinical and clinical research with the goal of developing curative drugs for cancer, HIV, COVID-19, HBV, and other infectious diseases.
- Type
- Private
- Status
- Active
- Founded
- 2008
- HQ
- Solna, SE | view all locations
- Website
- https://israb.se/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Solna, Stockholms län HQ
Sweden
Retzius väg 11
ISR Immune System Regulation Holding Financials
Summary Financials
- Gross profit (FY, 2022)
- kr1.3M
- Net income (FY, 2022)
- (kr218.6M)
- Cash (FY, 2022)
- kr253.0K
- EBIT (FY, 2022)
- (kr211.6M)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026